Who makes Ciclotiazide?

Ciclotiazide is developed by Pfizer.

What development phase is Ciclotiazide in?

Ciclotiazide is FDA-approved (marketed).

What is the generic name of Ciclotiazide?

CYCLOTHIAZIDE is the generic (nonproprietary) name of Ciclotiazide.

Last reviewed 2026-04-20 · How we verify

Ciclotiazide (CYCLOTHIAZIDE)

Pfizer · FDA-approved approved Small molecule Quality 16/100

At a glance

Generic name	CYCLOTHIAZIDE
Sponsor	Pfizer
Drug class	cyclothiazide
Target	Glutamate receptor 1, Glutamate receptor 2, Glutamate receptor 3
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1982

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Drug interactions

lithium

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ciclotiazide CI brief — competitive landscape report
Ciclotiazide updates RSS · CI watch RSS
Pfizer portfolio CI